Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Bone. 2016 Sep 15;93:79–85. doi: 10.1016/j.bone.2016.09.013

Figure 5.

Figure 5

Near infrared optical imaging of cathepsin K activatable substrate was visualized at 8 weeks. Subsequent imaging of probe administered at 11 and 14 weeks reveals transient reductions (11 wk) and restoration (14 wk) of osteoclast activity, particularly in Brtl/+ mice. Despite large variability, a general dose-dependent trend was noted across doses of pamidronate. + p<0.05 within sample repeated measure ANOVA showing effect of time following cessation.